Literature DB >> 14718021

Investigation of the incidence of hepatitis E virus among pregnant women in Turkey.

Arif Serhan Cevrioglu1, Mustafa Altindis, Hüseyin Mete Tanir, Fatih Aksoy.   

Abstract

AIM: The aim of our study was to determine the prevalence of hepatitis E virus (HEV) among pregnant and non-pregnant women in Middle Anatolia, identify the factors that affect being HEV positive and to study the effects of HEV positivity on mother and fetus.
METHODS: The study included 245 pregnant women who applied to various health centers and 76 cases in the same age range as the control. Blood samples taken from the cases were tested in terms of anti-HEV, IgM and IgG using the microELISA method.
RESULTS: None of the blood samples tested revealed anti-HEV IgM positive, an indicator of acute infection, while 31 pregnant women (12.6%) and nine cases in the control group (11.8%) were found to have anti-HEV IgG positive (P > 0.05). It was seen that in pregnant women such factors as advanced age, lower educational and income levels and rural residence were correlated with higher anti-HEV IgG positive values (P < 0.05). HEV infection is endemic in Afyon and its vicinity. There were no statistical differences between pregnant women and non-pregnant women at similar ages in terms of HEV seropositivity.
CONCLUSION: It can be suggested that pregnancy does not constitute a predisposition to HEV infection.

Entities:  

Mesh:

Year:  2004        PMID: 14718021     DOI: 10.1111/j.1341-8076.2004.00155.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  18 in total

1.  A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.

Authors:  Yueyuan Zhao; Xuefeng Zhang; Fengcai Zhu; Hui Jin; Bei Wang
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 2.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

Review 3.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 4.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

5.  Frequency of Acute Viral Hepatitis A, B, C, and E in Pregnant Women Presenting to Hayatabad Medical Complex, Peshawar, Pakistan.

Authors:  Ahmad R Khan; Salma Waqar; Zainab Rafiq; Rizwan Ullah; Muhammad Hayyan Wazir; Ayesha M Gul
Journal:  Cureus       Date:  2022-04-17

6.  Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt.

Authors:  Yahia Z Gad; Nasser Mousa; Maher Shams; Ahmed Elewa
Journal:  Asian J Transfus Sci       Date:  2011-07

7.  The Prevalence of Hepatitis E Virus Infection in the Adult Turkish Population: A Systematic Review of the Literature and Prevalence Study in Blood Donors in Mersin Province.

Authors:  Orhan Sezgin; Serkan Yaraş; Seda Tezcan Ülger; Gönül Aslan; Eyyüp Naci Tiftik
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

8.  HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh.

Authors:  Salimur Rahman; Mobin Khan; Fazal Karim
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

9.  A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy.

Authors:  Rahul Karna; Rajib K Hazam; Jayanta Borkakoti; Ashok Kumar; Premashis Kar
Journal:  J Clin Exp Hepatol       Date:  2019-10-03

10.  Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.

Authors:  Kuan Abdoulaye Traoré; Hortense Rouamba; Yacouba Nébié; Mahamadou Sanou; Alfred S Traoré; Nicolas Barro; Pierre Roques
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.